VBI Vaccines (NASDAQ:VBIV) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com started coverage on shares of VBI Vaccines (NASDAQ:VBIV – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Up 1.3 % VBI Vaccines stock opened at $0.59 on Friday. The stock has a market cap of […]

Leave a Reply

Your email address will not be published.

Previous post Jackson Financial (JXN) Set to Announce Quarterly Earnings on Wednesday
Next post Cantaloupe (NASDAQ:USAT) Coverage Initiated by Analysts at StockNews.com